stars 1 stars 2 stars 3

ATEM is a specialist cryo-EM CRO working exclusively in biologics development. We answer the specific structural and morphological questions that block pharma and biotech teams from advancing their programs — delivering panel-ready, decision-ready results at the speed development timelines demand. Our work spans three active product areas: * LNP characterization, where AI-enabled morphological analysis translates particle population data into formulation and process development decisions. * High-Throughput 3D Epitope Mapping, where structure determination of antibody-antigen complexes — including membrane protein targets — delivers mechanistic interpretation and actionable design recommendations for antibody engineering and discovery biology teams. * GMP Viral Contamination Testing, where morphological analytical assays under GMP conditions produce regulatory-defensible evidence for IND, BLA, and cell bank qualification submissions. Unlike generalist analytical providers, ATEM scopes every engagement to the question being asked — not the broadest analysis that can be justified. The deliverable is always the same: a clear answer to the client's development question, documented for regulatory or internal use, and interpreted in language the development team can act on directly. To find out more about ATEM, visit www.atem.bio

ATEM Structural Discovery Questions

Karl Bertram is the Co-founder | Managing Director ATEM Structural Discovery of ATEM Structural Discovery.

12 people are employed at ATEM Structural Discovery.

ATEM Structural Discovery is based in Remscheid, North Rhine-Westphalia.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users